Company intelligence / Profile preview

Transoma Medical

Saint Paul, Minnesota, USbiospace.com ↗

Ownership: Private
Development stage: Other

Overview

Transoma Medical developed and commercialized the Sleuth and Sleuth AT implantable wireless cardiac monitors for long-term patient heart rhythm tracking. The company also provided advanced telemetry solutions for preclinical drug testing in animals. Despite regulatory approvals and sales growth, it ceased operations in late 2009 after failing to secure additional funding. Clinical results showed utility of the device in diagnosing unexplained syncope and other arrhythmias; however, no new data or programs exist post-shutdown. Animal business continued briefly after closure of human operations.

Therapeutic areas: NeurologyCardiovascularOther
Modalities: DeviceWireless monitoring system
Industry: Implantable Medical Devices

Partnerships

Not specified; investors included Affinity Capital Partners.

Beyond the preview

Go deeper on Transoma Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transoma Medical.

Explore the full profile